Abbott's Innovations in Pulsed Field Ablation and Cardiac Mapping
Thursday, 10 October 2024, 06:31
Abbott's Recent Milestones in Pulsed Field Ablation
Abbott (NYSE: ABT) today announced new milestones supporting its suite of pulsed field ablation (PFA) solutions in electrophysiology. The ongoing research and advancements in PFA are set to revolutionize how electrophysiology procedures are performed.
New Cardiac Mapping Tool Launch
In addition to PFA developments, Abbott has launched a new cardiac mapping tool that enhances the precision and efficiency of cardiac procedures, leading to better patient outcomes.
Impact on Electrophysiology
- Abbott's PFA technology significantly reduces procedure times.
- Continuous research underlines Abbott's role in advancing cardiac care.
- Innovations contribute to safer and more effective treatment options.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.